NCT02327351View on ClinicalTrials.gov

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

June 30, 2018

Conditions
Primary Immune Deficiency DisorderHematopoietic Stem Cell Transplantation
Interventions
OTHER

Biological: TCR alfa beta T cell depletion

Trial Locations (1)

117997

Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology, Moscow

All Listed Sponsors
lead

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

OTHER

NCT02327351 - TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID | Biotech Hunter | Biotech Hunter